Inflammatory mediators in polycystic ovary syndrome: the case of interleukin-18

Arch Endocrinol Metab. 2022 Mar 8;66(1):1-2. doi: 10.20945/2359-3997000000455.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Case-Control Studies
  • Female
  • Humans
  • Inflammation Mediators
  • Insulin Resistance*
  • Interleukin-18
  • Polycystic Ovary Syndrome*

Substances

  • Inflammation Mediators
  • Interleukin-18